The Effectiveness of Idazoxan in Treating TRD

• Status: Withdrawn
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Assessing the effectiveness of Idazoxan as a treatment for depressive patients who did not respond to treatment with SSRI

• Phase: Phase 3

Details

• Lead Sponsor: Sheba Medical Center
• Treatments: Idazoxan

Criteria

Inclusion Criteria:

• MDD patients

• Did not respond to at least one treatment of 4-6 weeks of SSRI in adequate dose

• In or out patients

Exclusion Criteria:

• Psychotic symptoms